Natividad Lopez has significant experience in the pharmaceutical industry, currently serving as the New Asset Evaluation and Strategy Director for Neurology and Immune Inflammatory Diseases at Servier since September 2009. In addition, Natividad has held roles as the Study Team Leader and Clinical Development Leader in Oncology within the same company. Prior to Servier, Natividad worked at IRIS from 2005 to 2009 as a Chef de Projet Clinique in Internal Medicine, focusing on the clinical study of morbidity and mortality in the ADVANCE project.
This person is not in the org chart
This person is not in any teams
This person is not in any offices